C O M M U N I C A T I O N S
Scheme 1a
a Conditions: (a) pyrrole-1-carboxylic acid, DCC, Et3N, CH2Cl2, 65%; (b) tBuPh2SiCl, imidazole, DMF, 97%; (c) iBu2AlH, CH2Cl2, -90 °C; (d) allylamine,
BF3 ·OEt2, CH2Cl2, 56% (2 steps, >20:1 trans/cis); (e) Pd(PPh3)4, 1,3-dimethylbarbituric acid, CH2Cl2; then Na2CO3, TcesNd(SMe)Cl, 94%; (f) EtOSO2CF3,
i
2,4,6-tri-tert-butylpyrimidine, CH2Cl2, 47 °C, 78%; (g) NH3, NH4OAc, MeOH, 60 °C, 82%; (h) CCl3C(O)Cl, Pr2NEt, CH2Cl2, -20 °C, 87%; (i) 5 mol%
Rh2(esp)2, PhI(OAc)2, MgO, CH2Cl2, 42 °C, 61%; (j) Et3SiH, BF3 ·OEt2, CH2Cl2, 81%; (k) nBu4NF, THF; (l) Cl3CC(O)NCO, CH2Cl2, -20 °C; then MeOH,
76% (2 steps); (m) 2 mol% OsO4, NMO, THF/H2O, 81%; (n) PhC(O)CN, DMAP, CH2Cl2/MeCN, -78 °C, 67%; (o) Dess-Martin periodinane, CH2Cl2,
79%; (p) H2, Pd/C, CF3CO2H, MeOH; then NH3, MeOH, 83%; (q) DMF ·SO3, 2,6-di-tert-butyl-4-methylpyridine, NMP, 71%.
Removal of all three protecting groups in 12 through a single
References
operation affords 11ꢀ-hydroxysaxitoxin, which is isolated as the
(1) Seafood and Freshwater Toxins: Pharmacology, Physiology, and Detection;
Botana, L. M., Ed.; Marcel Dekker: New York, 2000.
(2) For leading reviews, see: (a) Llewellyn, L. E. Nat. Prod. Rep. 2006, 23,
200–222. (b) Hall, S.; Strichartz, G.; Moczydlowski, E.; Ravindran, A.;
Reichardt, P. B. ACS Symp. Series 1990, 418, 29–65.
-
bis-C3F7CO2 salt.4f Analytical data for this material (1H NMR,
HRMS) match those found in the literature.6a,b,16
(3) (a) Tetrodotoxin, Saxitoxin, and the Molecular Biology of the Sodium
Channel; Kao, C. Y., Levinson, S. R., Eds.; New York Academy of
Sciences: New York, 1986; Vol. 479. (b) Tikhonov, D. B.; Zhorov, B. S.
Biophys. J. 2005, 88, 184–197, and references therein.
(4) (a) Tanino, H.; Nakata, T.; Kaneko, T.; Kishi, Y. J. Am. Chem. Soc. 1977,
99, 2818–2819. (b) Kishi, Y. Heterocycles 1980, 14, 1477–1495. (c) Jacobi,
P. A.; Martinelli, M. J.; Polanc, S. J. Am. Chem. Soc. 1984, 106, 5594–
5598. (d) Martinelli, M. J.; Brownstein, A. D.; Jacobi, P. A.; Polanc, S.
Croat. Chem. Acta 1986, 59, 267–295. (e) Fleming, J. J.; Du Bois, J. J. Am.
Chem. Soc. 2006, 128, 3926–3927. (f) Fleming, J. J.; McReynolds, M. D.;
Du Bois, J. J. Am. Chem. Soc. 2007, 129, 9964–9975. Following their earlier
report, Kishi et al. have described an asymmetric synthesis of (-)-
decarbamoylsaxitoxin; see: (g) Hong, C. Y.; Kishi, Y. J. Am. Chem. Soc.
1992, 114, 7001–7006.
Figure 2. Epimerization at C11 occurs upon standing.
(5) Iwamoto, O.; Koshino, H.; Hashizume, D.; Nagasawa, K. Angew. Chem.,
Int. Ed. 2007, 46, 8625–8628.
To complete the synthesis of GTX 3, selective sulfation of
the C11 alcohol is achieved using DMF · SO3 in combination
with 2,6-di-tert-butyl-4-methylpyridine as an acid scavenger. The
(6) (a) Shimizu, Y.; Buckley, L. J.; Alam, M.; Oshima, Y.; Fallon, W. E.;
Kasai, H.; Miura, I.; Gullo, V. P.; Nakanishi, K. J. Am. Chem. Soc. 1976,
98, 5414–5416. (b) Boyer, G. L.; Schantz, E. J.; Schnoes, H. K. J. Chem.
Soc., Chem. Commun. 1978, 889–890. (c) Onodera, H.; Satake, M.; Oshima,
Y.; Yasumoto, T.; Carmichael, W. W. Nat. Toxins 1997, 5, 146–151.
(7) An approach to GTX 2 and 3 has been described, see: Hannick, S. M.;
Kishi, Y. J. Org. Chem. 1983, 48, 3833–3835.
-
pure toxin is obtained as the C3F7CO2 adduct following
reversed-phase HPLC. This material matches the reported
physical properties of natural GTX 3 in all respects and blocks
electrical transmission in heterologously expressed NaV1.4 ion
(8) Kim, M.; Mulcahy, J. V.; Espino, C. G.; Du Bois, J. Org. Lett. 2006, 8,
1073–1076.
(9) Analogous oxidation reactions with indole derivatives give evidence for a
zwitterionic intermediate; see: Padwa, A.; Flick, A. C.; Leverett, C. A.;
Stengel, T. J. Org. Chem. 2004, 69, 6377–6386.
(10) Boger, D. L.; Patel, M. J. Org. Chem. 1987, 52, 2319–2323.
(11) An X-ray crystal structure of a modified form of this intermediate confirms
the trans stereochemical assignment.
channels with an IC50 value of ∼20 nM (reported IC50
)
13.2-33.5 nM).17 Upon standing GTX 3 in aqueous solution at
pH ) 8, epimerization at C11 occurs to give GTX 2, also in
agreement with published observations (Figure 2).6a,16a
(12) The instability of this material on SiO2 is likely responsible for the reduced
The completed synthesis of GTX 3 offers a unique strategic
approach for preparing this family of guanidinium toxins and related
structures, while underscoring the power of Rh-catalyzed amination
for heterocycle assembly.18 Access to unnatural forms of the toxin
should be possible following this work.
isolated yields.
(13) The choice of solvent has a rather substantial influence on the performance
of this step, CH2Cl2 being the only medium in which complete consumption
of the starting guanidine 7 is observed.
(14) Kocovsky, P. Tetrahedron Lett. 1986, 27, 5521–5524.
(15) Hexavalent chromium, TEMPO, and DMSO-based oxidation protocols
universally consumed starting material without generating ketone 12.
(16) (a) Wichmann, C. F.; Boyer, G. L.; Divan, C. L.; Schantz, E. J.; Schnoes,
H. K. Tetrahedron Lett. 1981, 22, 1941–1944. (b) Shimizu, Y.; Kobayashi,
M.; Genenah, A.; Oshima, Y. Tetrahedron 1984, 40, 539–544.
(17) (a) Choudhary, G.; Shang, L.; Li, X.; Dudley, S. C., Jr. Biophys. J. 2002,
83, 912–919. (b) Kao, C. Y.; Kao, P. N.; James-Kracke, M. R.; Koehn,
F. E.; Wichmann, C. F.; Schnoes, H. K. Toxicon 1985, 23, 647–655.
(18) An attempt to utilize guanidine C-H insertion for assembling bromopyrrole-
derived natural products has been described; see: (a) Wang, S.; Romo, D.
Angew. Chem., Int. Ed. 2008, 47, 1284–1286. For a recent review of this
family of molecules, see:(b) Ko¨ck, M.; Grube, A.; Seiple, I. B.; Baran,
P. S. Angew. Chem., Int. Ed. 2007, 46, 6586–6594.
Acknowledgment. J.V.M. is grateful to the National Science
Foundation for a graduate fellowship. This work has been supported
by a grant from the NIH and by generous gifts from Pfizer, Amgen,
Boehringer-Ingelheim, and GlaxoSmithKline.
Supporting Information Available: Analytical data for selected
compounds. This material is available free of charge via the Internet
JA805651G
9
J. AM. CHEM. SOC. VOL. 130, NO. 38, 2008 12631